Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jan 20, 2026
Reporting period
Not applicable
Filed with the SEC
Jan 21, 2026
CFOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001907056-26-000004
Filed / recorded
Jan 21, 2026, 9:23 PM UTC
Added to OQRO
Oct 6, 2026, 7:59 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Hims & Hers Health, Inc.
Issuer CIK
1773751
Ticker
HIMS
Reporting person
Oluyemi Okupe
Relationship
Officer
Officer title
Chief Financial Officer
Security
Stock Option (right to buy)
Table
Derivative (Table II)
Transaction date
Jan 20, 2026
Transaction code
M
Shares / units
7,317
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
149,313
Ownership form
Direct
Amendment
No
Footnotes from the filing
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022.